A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation published by Cell Press is a new broad-scope, open access journal publishing
basic and applied research that has impact for the benefit of society.
On the cover: In recent years, driven by the new round of scientific and technological revolution coupled with carbon neutrality, the energy structure is undergoing unprecedented changes. Biomass energy can be obtained from abundant resources by a number of application ways, which is zero-carbon and has unique effect of carbon negative emission. Meanwhile, advanced conversion technologies, such as BECCS, pyrolysis, and biohydrogen, are also joining the way to make a better bioenergy. Clean products of biomass have been promoted to a prospective future. Combination of biomass energy development and advanced technology will realize a more flexible and imaginative use of biomass, contributing to a green, low-carbon and sustainable development. For a bright and recyclable future, we should improve the use of biomass energy and unlock its huge potential for energy conservation and carbon reduction.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > May 15, 2023 Volume 4, Issue 3
Novel microfluidic device for measurable residual disease detection in acute leukemia
Category:   Translational Patent   Download:  PDF  Figure  Endnote
Author: Ziwei Cai, Shuang Fan, Xiaoyi Sun, Xiaodong Mo, Gen Yang

e2.jpg

Principle and methodology of utilizing CTC enrichment chips in MRD detection


Relapse is the most important cause of treatment failure in acute leukemia (AL). Thus, how to predict relapse is critical for improving the survival of patients with AL. Measurable residual diseases (MRDs; previously termed minimal residual diseases), referring to the presence of remaining leukemia cells after the declaration of complete remission (CR) detected by morphological analysis, is the most important biomarker for relapse prediction.1 Several methods, including multiparameter flow cytometry (MFC), real-time quantitative polymerase chain reaction (qPCR), digital PCR (dPCR), and next-generation sequencing (NGS), are used to monitor MRD after treatment, reaching a sensitivity of 10−4 to 10−6.





Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry
COVID-19
Environment Changes
Geoscience
Life Sciences
Materials
Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org
  Official£º
Astronomy£º
Chemistry£º
Geoscience£º
Informatics£º
Life Science£º
Management£º
Materials£º
Medicine£º
Physics£º
ScienceX£º

@The_InnovationJ
@Innov_Astronomy
@InnovationChem
@Innov_Geosci
@Innov_inf
@Innov_LifeSci
@Innov_MGT
@Innov_Materials
@Innov_Medicine
@InnovationPhys
@Innov_ScienceX

  Copyright © 2019-2023 the-innovation.org All Rights Reserved